HEADER HYDROLASE/HYDROLASE INHIBITOR 16-APR-98 1A94
TITLE STRUCTURAL BASIS FOR SPECIFICITY OF RETROVIRAL PROTEASES
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PROTEASE;
COMPND 3 CHAIN: A, B, D, E;
COMPND 4 EC: 3.4.23.16;
COMPND 5 ENGINEERED: YES;
COMPND 6 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1;
SOURCE 3 ORGANISM_TAXID: 11676;
SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS HUMAN IMMUNODEFICIENCY VIRUS PROTEASE, ROUS SARCOMA VIRUS PROTEASE,
KEYWDS 2 PROTEIN-MEDIATED INTERACTION, VIRAL MATURATION, HYDROLASE-HYDROLASE
KEYWDS 3 INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR J.WU,J.M.ADOMAT,T.W.RIDKY,J.M.LOUIS,J.LEIS,R.W.HARRISON,I.T.WEBER
REVDAT 6 07-FEB-24 1A94 1 REMARK
REVDAT 5 03-NOV-21 1A94 1 REMARK SEQADV
REVDAT 4 13-JUL-11 1A94 1 VERSN
REVDAT 3 24-FEB-09 1A94 1 VERSN
REVDAT 2 16-FEB-99 1A94 1 SOURCE COMPND REMARK KEYWDS
REVDAT 2 2 1 HEADER
REVDAT 1 13-JAN-99 1A94 0
JRNL AUTH J.WU,J.M.ADOMAT,T.W.RIDKY,J.M.LOUIS,J.LEIS,R.W.HARRISON,
JRNL AUTH 2 I.T.WEBER
JRNL TITL STRUCTURAL BASIS FOR SPECIFICITY OF RETROVIRAL PROTEASES.
JRNL REF BIOCHEMISTRY V. 37 4518 1998
JRNL REFN ISSN 0006-2960
JRNL PMID 9521772
JRNL DOI 10.1021/BI972183G
REMARK 2
REMARK 2 RESOLUTION. 2.00 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : X-PLOR 3.1
REMARK 3 AUTHORS : BRUNGER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 100000.000
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.1000
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 86.1
REMARK 3 NUMBER OF REFLECTIONS : 20524
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : NULL
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.182
REMARK 3 FREE R VALUE : 0.281
REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT : NULL
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : NULL
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.09
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 802
REMARK 3 BIN R VALUE (WORKING SET) : 0.2793
REMARK 3 BIN FREE R VALUE : 0.3083
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 0.12
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 94
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 3024
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 118
REMARK 3 SOLVENT ATOMS : 181
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.30
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM SIGMAA (A) : NULL
REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM C-V SIGMAA (A) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.014
REMARK 3 BOND ANGLES (DEGREES) : 2.130
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 27.07
REMARK 3 IMPROPER ANGLES (DEGREES) : 1.700
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PARACSDX.PRO
REMARK 3 PARAMETER FILE 2 : PARAM19.SOL
REMARK 3 PARAMETER FILE 3 : NULL
REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO
REMARK 3 TOPOLOGY FILE 2 : TOPF19.SOL
REMARK 3 TOPOLOGY FILE 3 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1A94 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 100 THE DEPOSITION ID IS D_1000170547.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : NOV-96
REMARK 200 TEMPERATURE (KELVIN) : 293
REMARK 200 PH : 4.7
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418
REMARK 200 MONOCHROMATOR : NI FILTER
REMARK 200 OPTICS : MIRRORS
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : RIGAKU
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS
REMARK 200 DATA SCALING SOFTWARE : R-AXIS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20944
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000
REMARK 200 RESOLUTION RANGE LOW (A) : 8.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 86.1
REMARK 200 DATA REDUNDANCY : NULL
REMARK 200 R MERGE (I) : 0.08300
REMARK 200 R SYM (I) : 0.18200
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 2.0000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.25
REMARK 200 COMPLETENESS FOR SHELL (%) : 76.5
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : 0.08300
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: NULL
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 44.67
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.22
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: PH 4.7
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 1 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z+1/2
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.85000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 5410 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 9190 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 5450 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 9180 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -30.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT
REMARK 500
REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT.
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE
REMARK 500 HH11 ARG B 57 HH TYR B 59 1.16
REMARK 500 H1 HOH A 701 O HOH A 727 1.54
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 PRO D 79 C - N - CA ANGL. DEV. = 10.5 DEGREES
REMARK 500 ASP E 25 CB - CG - OD1 ANGL. DEV. = 5.7 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 GLN A 61 54.90 33.75
REMARK 500 GLU D 34 153.16 -48.63
REMARK 500 PRO D 79 48.14 -72.02
REMARK 500 GLU E 35 123.93 -33.63
REMARK 500 PRO E 79 53.61 -64.91
REMARK 500
REMARK 500 REMARK: NULL
REMARK 600
REMARK 600 HETEROGEN
REMARK 600
REMARK 600 PEPTIDE INHIBITOR 0Q4 HAS A REDUCED PEPTIDE (-CH2-NH) INSTEAD
REMARK 600 OF THE NORMAL PEPTIDE LINK (-CO-NH).
REMARK 630
REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR
REMARK 630 MOLECULE NAME: N-[(2R)-2-({N~5~-[AMINO(IMINIO)METHYL]-L-ORNITHYL-L-
REMARK 630 VALYL}AMINO)-4-METHYLPENTYL]-L-PHENYLALANYL-L-ALPHA-GLUTAMYL-L-
REMARK 630 ALANYL-L-NORLEUCINAMIDE
REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 630
REMARK 630 M RES C SSSEQI
REMARK 630 0Q4 A 100
REMARK 630 0Q4 E 100
REMARK 630 SOURCE: NULL
REMARK 630 TAXONOMY: NULL
REMARK 630 SUBCOMP: ARG VAL DC0 GLU ALA NLE NH2
REMARK 630 DETAILS: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0Q4 A 100
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0Q4 E 100
REMARK 999
REMARK 999 SEQUENCE
REMARK 999 MUTATIONS Q7K, L33I, L63I, C67A, C95A, HAVE BEEN MADE TO
REMARK 999 STABILIZE THE PROTEASE FROM AUTOPROTEOLYSIS, WHILE
REMARK 999 RETAINING ACTIVITY SIMILAR TO WILD-TYPE HIV-1 PROTEASE
DBREF 1A94 A 1 99 UNP P03367 POL_HV1BR 69 167
DBREF 1A94 B 1 99 UNP P03367 POL_HV1BR 69 167
DBREF 1A94 D 1 99 UNP P03367 POL_HV1BR 69 167
DBREF 1A94 E 1 99 UNP P03367 POL_HV1BR 69 167
SEQADV 1A94 LYS A 7 UNP P03367 GLN 75 ENGINEERED MUTATION
SEQADV 1A94 ILE A 33 UNP P03367 LEU 101 ENGINEERED MUTATION
SEQADV 1A94 GLU A 43 UNP P03367 LYS 111 ENGINEERED MUTATION
SEQADV 1A94 ILE A 63 UNP P03367 LEU 131 ENGINEERED MUTATION
SEQADV 1A94 ALA A 67 UNP P03367 CYS 135 ENGINEERED MUTATION
SEQADV 1A94 ALA A 95 UNP P03367 CYS 163 ENGINEERED MUTATION
SEQADV 1A94 LYS B 7 UNP P03367 GLN 75 ENGINEERED MUTATION
SEQADV 1A94 ILE B 33 UNP P03367 LEU 101 ENGINEERED MUTATION
SEQADV 1A94 GLU B 43 UNP P03367 LYS 111 ENGINEERED MUTATION
SEQADV 1A94 ILE B 63 UNP P03367 LEU 131 ENGINEERED MUTATION
SEQADV 1A94 ALA B 67 UNP P03367 CYS 135 ENGINEERED MUTATION
SEQADV 1A94 ALA B 95 UNP P03367 CYS 163 ENGINEERED MUTATION
SEQADV 1A94 LYS D 7 UNP P03367 GLN 75 ENGINEERED MUTATION
SEQADV 1A94 ILE D 33 UNP P03367 LEU 101 ENGINEERED MUTATION
SEQADV 1A94 GLU D 43 UNP P03367 LYS 111 ENGINEERED MUTATION
SEQADV 1A94 ILE D 63 UNP P03367 LEU 131 ENGINEERED MUTATION
SEQADV 1A94 ALA D 67 UNP P03367 CYS 135 ENGINEERED MUTATION
SEQADV 1A94 ALA D 95 UNP P03367 CYS 163 ENGINEERED MUTATION
SEQADV 1A94 LYS E 7 UNP P03367 GLN 75 ENGINEERED MUTATION
SEQADV 1A94 ILE E 33 UNP P03367 LEU 101 ENGINEERED MUTATION
SEQADV 1A94 GLU E 43 UNP P03367 LYS 111 ENGINEERED MUTATION
SEQADV 1A94 ILE E 63 UNP P03367 LEU 131 ENGINEERED MUTATION
SEQADV 1A94 ALA E 67 UNP P03367 CYS 135 ENGINEERED MUTATION
SEQADV 1A94 ALA E 95 UNP P03367 CYS 163 ENGINEERED MUTATION
SEQRES 1 A 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE
SEQRES 2 A 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 A 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO
SEQRES 4 A 99 GLY ARG TRP GLU PRO LYS MET ILE GLY GLY ILE GLY GLY
SEQRES 5 A 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU
SEQRES 6 A 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY
SEQRES 7 A 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR
SEQRES 8 A 99 GLN ILE GLY ALA THR LEU ASN PHE
SEQRES 1 B 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE
SEQRES 2 B 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 B 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO
SEQRES 4 B 99 GLY ARG TRP GLU PRO LYS MET ILE GLY GLY ILE GLY GLY
SEQRES 5 B 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU
SEQRES 6 B 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY
SEQRES 7 B 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR
SEQRES 8 B 99 GLN ILE GLY ALA THR LEU ASN PHE
SEQRES 1 D 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE
SEQRES 2 D 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 D 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO
SEQRES 4 D 99 GLY ARG TRP GLU PRO LYS MET ILE GLY GLY ILE GLY GLY
SEQRES 5 D 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU
SEQRES 6 D 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY
SEQRES 7 D 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR
SEQRES 8 D 99 GLN ILE GLY ALA THR LEU ASN PHE
SEQRES 1 E 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE
SEQRES 2 E 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 E 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO
SEQRES 4 E 99 GLY ARG TRP GLU PRO LYS MET ILE GLY GLY ILE GLY GLY
SEQRES 5 E 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU
SEQRES 6 E 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY
SEQRES 7 E 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR
SEQRES 8 E 99 GLN ILE GLY ALA THR LEU ASN PHE
HET 0Q4 A 100 73
HET 0Q4 E 100 73
HETNAM 0Q4 N-[(2R)-2-({N~5~-[AMINO(IMINIO)METHYL]-L-ORNITHYL-L-
HETNAM 2 0Q4 VALYL}AMINO)-4-METHYLPENTYL]-L-PHENYLALANYL-L-ALPHA-
HETNAM 3 0Q4 GLUTAMYL-L-ALANYL-L-NORLEUCINAMIDE
HETSYN 0Q4 INHIBITOR ANALOGUES OF CA-P2
FORMUL 5 0Q4 2(C40 H70 N11 O8 1+)
FORMUL 7 HOH *181(H2 O)
HELIX 1 1 ARG A 87 LEU A 90 1 4
HELIX 2 2 ARG B 87 ILE B 93 1 7
HELIX 3 3 ARG D 87 LEU D 90 1 4
HELIX 4 4 ARG E 87 LEU E 90 1 4
SHEET 1 A 4 GLN A 18 LEU A 23 0
SHEET 2 A 4 LEU A 10 ILE A 15 -1 N ILE A 15 O GLN A 18
SHEET 3 A 4 ILE A 62 ILE A 66 -1 N GLU A 65 O LYS A 14
SHEET 4 A 4 HIS A 69 GLY A 73 -1 N GLY A 73 O ILE A 62
SHEET 1 B 3 GLU A 43 GLY A 49 0
SHEET 2 B 3 GLY A 52 TYR A 59 -1 N GLN A 58 O GLU A 43
SHEET 3 B 3 VAL A 75 GLY A 78 -1 N VAL A 77 O ARG A 57
SHEET 1 C 4 GLN B 18 LEU B 23 0
SHEET 2 C 4 LEU B 10 ILE B 15 -1 N ILE B 15 O GLN B 18
SHEET 3 C 4 ILE B 62 ILE B 66 -1 N GLU B 65 O LYS B 14
SHEET 4 C 4 HIS B 69 GLY B 73 -1 N GLY B 73 O ILE B 62
SHEET 1 D 4 VAL B 32 GLU B 34 0
SHEET 2 D 4 VAL B 75 GLY B 78 1 N LEU B 76 O ILE B 33
SHEET 3 D 4 GLY B 52 TYR B 59 -1 N TYR B 59 O VAL B 75
SHEET 4 D 4 GLU B 43 GLY B 49 -1 N GLY B 49 O GLY B 52
SHEET 1 E 4 GLN D 18 LEU D 23 0
SHEET 2 E 4 LEU D 10 ILE D 15 -1 N ILE D 15 O GLN D 18
SHEET 3 E 4 ILE D 62 ILE D 66 -1 N GLU D 65 O LYS D 14
SHEET 4 E 4 HIS D 69 GLY D 73 -1 N GLY D 73 O ILE D 62
SHEET 1 F 4 VAL D 32 GLU D 34 0
SHEET 2 F 4 VAL D 75 GLY D 78 1 N LEU D 76 O ILE D 33
SHEET 3 F 4 PHE D 53 TYR D 59 -1 N TYR D 59 O VAL D 75
SHEET 4 F 4 GLU D 43 GLY D 48 -1 N ILE D 47 O ILE D 54
SHEET 1 G 4 GLN E 18 LEU E 23 0
SHEET 2 G 4 LEU E 10 ILE E 15 -1 N ILE E 15 O GLN E 18
SHEET 3 G 4 ILE E 62 ILE E 66 -1 N GLU E 65 O LYS E 14
SHEET 4 G 4 HIS E 69 GLY E 73 -1 N GLY E 73 O ILE E 62
SHEET 1 H 4 VAL E 32 GLU E 34 0
SHEET 2 H 4 VAL E 75 GLY E 78 1 N LEU E 76 O ILE E 33
SHEET 3 H 4 GLY E 52 TYR E 59 -1 N TYR E 59 O VAL E 75
SHEET 4 H 4 GLU E 43 GLY E 49 -1 N GLY E 49 O GLY E 52
SITE 1 AC1 25 ARG A 8 LEU A 23 ASP A 25 GLY A 27
SITE 2 AC1 25 ALA A 28 ASP A 29 ASP A 30 MET A 46
SITE 3 AC1 25 ILE A 47 GLY A 48 GLY A 49 PRO A 81
SITE 4 AC1 25 VAL A 82 HOH A 442 HOH A 511 ASP B 25
SITE 5 AC1 25 GLY B 27 ALA B 28 ASP B 29 ASP B 30
SITE 6 AC1 25 GLY B 48 GLY B 49 ILE B 84 HOH D1742
SITE 7 AC1 25 TRP E 6
SITE 1 AC2 29 TRP B 6 ARG D 8 LEU D 23 ASP D 25
SITE 2 AC2 29 GLY D 27 ALA D 28 ASP D 29 MET D 46
SITE 3 AC2 29 GLY D 48 GLY D 49 ILE D 50 PRO D 81
SITE 4 AC2 29 VAL D 82 ILE D 84 HOH D1767 ASP E 25
SITE 5 AC2 29 GLY E 27 ALA E 28 ASP E 29 ASP E 30
SITE 6 AC2 29 LYS E 45 MET E 46 ILE E 47 GLY E 48
SITE 7 AC2 29 GLY E 49 ILE E 50 PHE E 53 HOH E 438
SITE 8 AC2 29 HOH E1511
CRYST1 59.610 51.940 61.700 90.00 90.00 90.00 P 1 1 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.016776 0.000000 0.000000 0.00000
SCALE2 0.000000 0.019253 0.000000 0.00000
SCALE3 0.000000 0.000000 0.016207 0.00000